Literature DB >> 22927672

Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.

Ian Kelleher1, Mary C Clarke, Caroline Rawdon, Jennifer Murphy, Mary Cannon.   

Abstract

Neurocognitive dysfunction is well established in psychosis, but recent work suggests that processing speed deficits might represent a particularly important cognitive deficit. A number of significant confounds, however, such as disease chronicity and antipsychotic medication use, have been shown to affect processing speed, causing debate as to the core cognitive features of psychosis. We adopted a novel strategy of testing neurocognitive performance in the "extended psychosis phenotype," involving community-based adolescents who are not clinically psychotic but who report psychotic symptoms and who are at increased risk of psychosis in adulthood. This allows investigation of the earliest cognitive factors associated with psychosis risk, while excluding potential confounds such as disease chronicity and antipsychotic use. A population sample of 212 school-going adolescents aged 11-13 years took part in this study. Psychotic symptoms were assessed using the psychosis section of the Schedule for Affective Disorders and Schizophrenia. Neurocognition was assessed using the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) consensus neurocognitive battery. Adolescents with psychotic symptoms performed significantly more poorly on 3 processing speed tasks: Trail Making Test-A (F = 3.3, P < .05), Trail Making Test-B (F = 3.1, P < .05), and digit symbol coding task (F = 7.0, P < .001)-as well as on a nonverbal working memory (spatial span) task (F = 3.2, P < .05). Our findings support the idea that neurocognitive impairment, and processing speed impairment in particular, is a core feature of psychosis risk. This group likely demonstrates some of the earliest cognitive impairments associated with psychosis vulnerability.

Entities:  

Keywords:  adolescents; cognition; epidemiology

Mesh:

Year:  2012        PMID: 22927672      PMCID: PMC3756771          DOI: 10.1093/schbul/sbs086

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  48 in total

1.  Neuropsychological status of subjects at high risk for a first episode of psychosis.

Authors:  K A Hawkins; J Addington; R S E Keefe; B Christensen; D O Perkins; R Zipurksy; S W Woods; T J Miller; E Marquez; A Breier; T H McGlashan
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

2.  Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample.

Authors:  James Scott; David Chant; Gavin Andrews; John McGrath
Journal:  Psychol Med       Date:  2005-11-23       Impact factor: 7.723

3.  Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample.

Authors:  R Goodman; T Ford; H Simmons; R Gatward; H Meltzer
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

4.  Social adversity in childhood and the risk of developing psychosis: a national cohort study.

Authors:  Susanne Wicks; Anders Hjern; David Gunnell; Glyn Lewis; Christina Dalman
Journal:  Am J Psychiatry       Date:  2005-09       Impact factor: 18.112

5.  The measurement of differential deficit.

Authors:  L J Chapman; J P Chapman
Journal:  J Psychiatr Res       Date:  1978       Impact factor: 4.791

6.  Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.

Authors:  R Poulton; A Caspi; T E Moffitt; M Cannon; R Murray; H Harrington
Journal:  Arch Gen Psychiatry       Date:  2000-11

7.  A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings.

Authors:  Tara A Niendam; Carrie E Bearden; Isabelle M Rosso; Laura E Sanchez; Trevor Hadley; Keith H Nuechterlein; Tyrone D Cannon
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

Review 8.  Schizophrenia: a disconnection syndrome?

Authors:  K J Friston; C D Frith
Journal:  Clin Neurosci       Date:  1995

9.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

10.  Spatial working memory ability is a marker of risk-for-psychosis.

Authors:  S J Wood; C Pantelis; T Proffitt; L J Phillips; G W Stuart; J A Buchanan; K Mahony; W Brewer; D J Smith; P D McGorry
Journal:  Psychol Med       Date:  2003-10       Impact factor: 7.723

View more
  30 in total

1.  Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.

Authors:  S Kristian Hill; Alison Buchholz; Hayley Amsbaugh; James L Reilly; Leah H Rubin; James M Gold; Richard S E Keefe; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney
Journal:  Schizophr Res       Date:  2015-05-23       Impact factor: 4.939

2.  Disruptions in White Matter Maturation and Mediation of Cognitive Development in Youths on the Psychosis Spectrum.

Authors:  Catherine E Hegarty; Dietsje D Jolles; Eva Mennigen; Maria Jalbrzikowski; Carrie E Bearden; Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-12-27

3.  Abnormal resting state FMRI activity predicts processing speed deficits in first-episode psychosis.

Authors:  Miklos Argyelan; Juan A Gallego; Delbert G Robinson; Toshikazu Ikuta; Deepak Sarpal; Majnu John; Peter B Kingsley; John Kane; Anil K Malhotra; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

4.  Strange-face-in-the-mirror illusion and schizotypy during adolescence.

Authors:  Eduardo Fonseca-Pedrero; Deborah Badoud; Lia Antico; Giovanni B Caputo; Stephan Eliez; Sophie Schwartz; Martin Debbané
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

5.  Psychotic experiences and their significance.

Authors:  Alison R Yung; Ashleigh Lin
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

6.  Psychosis risk screening: Validation of the youth psychosis at-risk questionnaire - brief in a community-derived sample of adolescents.

Authors:  Eduardo Fonseca-Pedrero; Javier Ortuño-Sierra; Edurne Chocarro; Felix Inchausti; Martin Debbané; Julio Bobes
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-27       Impact factor: 4.035

7.  Resting-state connectivity deficits associated with impaired inhibitory control in non-treatment-seeking adolescents with psychotic symptoms.

Authors:  S C Jacobson McEwen; C G Connolly; A M C Kelly; I Kelleher; E O'Hanlon; M Clarke; M Blanchard; S McNamara; D Connor; E Sheehan; G Donohoe; M Cannon; H Garavan
Journal:  Acta Psychiatr Scand       Date:  2013-04-26       Impact factor: 6.392

8.  Processing Speed is Impaired in Adults with Autism Spectrum Disorder, and Relates to Social Communication Abilities.

Authors:  Sarah M Haigh; Jennifer A Walsh; Carla A Mazefsky; Nancy J Minshew; Shaun M Eack
Journal:  J Autism Dev Disord       Date:  2018-08

9.  Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.

Authors:  William S Stone; Raquelle I Mesholam-Gately; Anthony J Giuliano; Kristen A Woodberry; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert W McCarley; Robert Heinssen; Michael F Green; Keith Nuechterlein; Larry J Seidman
Journal:  Schizophr Res       Date:  2016-02-16       Impact factor: 4.939

10.  Psychosis as a transdiagnostic and extended phenotype in the general population.

Authors:  Jim van Os; Uli Reininghaus
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.